Trials / Completed
CompletedNCT00884247
Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity
A Prospective, Non Interventional Study to Evaluate the Effects on Quality of Life, Symptoms and Productivity in Patients With Gastroesophageal Reflux Disease (GERD) After 6 Weeks Structured Treatment in a Company Health Care Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 36 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to evaluate if a GERD treatment programme, in accordance with current regional recommendations, in a company health care setting, has an impact on health related quality of life (HRQoL), symptoms, and productivity in GERD patients.
Conditions
Timeline
- Start date
- 2009-04-01
- Completion
- 2009-06-01
- First posted
- 2009-04-20
- Last updated
- 2010-12-07
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT00884247. Inclusion in this directory is not an endorsement.